1887

Abstract

Primary infection of macaques with simian immunodeficiency virus (SIV) as a model of human immunodeficiency virus (HIV) infection represents a unique opportunity to investigate early lentivirus-host interactions. In order to gain insight into immunopathogenic events taking place in the lung during lentiviral infection, we analysed lymphocyte expansion in the lung and chemokine secretion by mononuclear cells obtained by bronchoalveolar lavage (BALMCs) during primary infection by a pathogenic and a non-pathogenic SIV. Two groups of cynomolgus macaques were inoculated intravenously with a fully pathogenic isolate of SIVmac251 or with an attenuated, nef-deleted, molecular clone of SIVmac251. Spontaneous MIP-1alpha, MIP-1beta and RANTES production was assessed by ELISA in supernatants of short-term cultured BALMCs. Kinetics of haematological, virological and immunological parameters were investigated simultaneously. All 11 inoculated animals became infected. Monkeys inoculated with the nef-deleted SIV clone exhibited a significantly reduced plasma virus load and a less pronounced accumulation of lymphocytes in the lung compared to monkeys infected with the pathogenic SIVmac251 isolate. Compared to pre-infection levels, we observed an increase in the levels of RANTES, MIP1-alpha and MIP1-beta production in the two groups of monkeys, by the time of peak viraemia. Strikingly, a greater enhancement of RANTES and MIP-1alpha production was detected in monkeys infected with the attenuated virus. Given the potential influence of beta-chemokines on the immune response and virus replication, such results suggest that RANTES, MIP1-alpha and MIP1-beta could contribute to the singular features of the immune response elicited during infection of macaques with an attenuated SIV.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-80-3-767
1999-03-01
2023-01-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/80/3/0800767a.html?itemId=/content/journal/jgv/10.1099/0022-1317-80-3-767&mimeType=html&fmt=ahah

References

  1. Agostini C., Zambello R., Trentin L., Semenzato G. 1996; HIV and pulmonary immune responses. Immunology Today 17:359–364
    [Google Scholar]
  2. Almond N., Kent K., Cranage M., Rud E., Clarke B., Stott E. J. 1995; Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. Lancet 345:1342–1344
    [Google Scholar]
  3. Baba T. W., Jeong Y. S., Penninck D., Bronson R., Greene M. F., Ruprecht R. M. 1995; Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science 267:1820–1825
    [Google Scholar]
  4. Bach M. C. 1987; Zidovudine for lymphocytic interstitial pneumonia associated with AIDS. Lancet ii:796
    [Google Scholar]
  5. Barker E., Bossart K. N., Levy J. A. 1998; Primary CD8+ cells from HIV-infected individuals can suppress productive infection of macrophages independent of fi-chemokines. Proceedings of the National Academy of Sciences, USA 95:1725–1729
    [Google Scholar]
  6. Benveniste O., Vaslin B., Le Grand R., Cheret A., Matheux F., Théodoro F., Cranage M. P., Dormont D. 1996; Comparative interleukin (IL)-2/interferon (IFN)-y and IL-4/IL-10 responses during acute infection of macaques inoculated with attenuated nef-truncated or pathogenic SIVmac251 virus. Proceedings of the National Academy of Sciences, USA 93:3658–3663
    [Google Scholar]
  7. Brodie S. J., Marcom K. A., Pearson L. D., Anderson B. C., de la Concha-Bermejillo A., Ellis J. A., DeMartini J. C. 1992; Effects of virus load in the pathogenesis of lentivirus-induced lymphoid interstitial pneumonia. Journal of Infectious Diseases 166:531–541
    [Google Scholar]
  8. Butcher E. C., Picker L. J. 1996; Lymphocyte homing and homeostasis. Science 272:60–66
    [Google Scholar]
  9. Campbell J. J., Hedrick J., Zlotnik A., Siani M. A., Thompson D. A., Butcher E. C. 1998; Chemokines and the arrest of lymphocytes rolling under flow conditions. Science 279:381–384
    [Google Scholar]
  10. Canque B., Rosenzwajg M., Gey A., Tartour E., Fridman W. H., Gluckman J. C. 1996; Macrophage inflammatory protein-1α is induced by human immunodeficiency virus infection of monocyte-derived macrophages. Blood 87:2011–2019
    [Google Scholar]
  11. Chakrabarti L., Baptiste L., Khatissian E., Cumont M. C., Aubertin A. M., Montagnier L., Hurtrel B. 1995; Limited viral spread and rapid immune response in lymph nodes of macaques inoculated with attenuated simian immunodeficiency virus. Virology 213:535–548
    [Google Scholar]
  12. Chéret A., Le Grand R., Caufour P., Dereuddre-Bosquet N., Matheux F., Neildez O., Théodoro F., Maestrali N., Benveniste O., Vaslin B., Dormont D. 1996; Cytokine mRNA expression in mononuclear cells from different tissues during acute SIVmac251 infection ofmacaques. AIDS Research and Human Retroviruses 12:1263–1272
    [Google Scholar]
  13. Clements J. E., Montelaro R. C., Zink M. C., Amedee A. M., Miller S., Trichel A. M., Jagerski B., Hauer D., Martin L. N., Bohm R. P. and others 1995; Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus. Journal of Virology 69:2737–2744
    [Google Scholar]
  14. Cocchi F., DeVico A. L., Garzino-Demo A., Arya S. K., Gallo R. C., Lusso P. 1995; Identification of RANTES, MIP-1α, and MIP-lβ as the major HIV-suppressive factors produced by CD8+ T cells. Science 270:1811–1815
    [Google Scholar]
  15. Coffey M. J., Woffendin C., Phare S. M., Strieter R. M., Markovitz D. M. 1997; RANTES inhibits HIV-1 replication in human peripheral blood monocytes and alveolar macrophages. American Journal of Physiology 272:L1025–L1029
    [Google Scholar]
  16. Cohen J. 1997; Weakened SIV vaccine still kills. Science 278:24–25
    [Google Scholar]
  17. Dairaghi D. J., Soo K. S., Oldham E. R., Premack B. A., Kitamura T., Bacon K. B., Schall T. J. 1998; RANTES-induced T cell activation correlates with CD3 expression. Journal of Immunology 160:426–433
    [Google Scholar]
  18. Daniel M. D., Letvin N. L., King N. W., Kannagi M., Sehgal P. K., Kanki P. K., Essex M., Desrosiers R. C. 1985; Isolation of a T-cell tropic HTLV-III-like retrovirus from macaques. Science 228:1200–1204
    [Google Scholar]
  19. Daniel M. D., Kirchoff F., Czajak S. C., Sehgal P. K., Desrosiers R. C. 1992; Protective effects of a live-attenuated SIV vaccine with a deletion in the nef gene. Science 258:1938–1941
    [Google Scholar]
  20. Denis M., Ghadirian E. 1994; Alveolar macrophages from subjects infected with HIV-1 express macrophage inflammatory protein 1a (MIP-1α): contribution to the CD8+ alveolitis. Clinical and Experimental Immunology 96:187–192
    [Google Scholar]
  21. Dittmer U., Nisslein T., Bodemer W., Petry H., Sauermann U., Stahl-Hennig C., Hunsmann G. 1995; Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus. Virology 212:392–397
    [Google Scholar]
  22. Gauduin M.-C., Glickman R. L., Means R., Johnson R. P. 1998; Inhibition of simian immunodeficiency virus (SIV) replication by CD8+ T lymphocytes from macaques immunized with live attenuated SIV. Journal of Virology 72:6315–6324
    [Google Scholar]
  23. Johnson R. P., Glickman R. L., Yang J. Q., Kaur A., Dion J. T., Mulligan M. J., Desrosiers R. C. 1997; Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus. Journal of Virology 71:7711–7718
    [Google Scholar]
  24. Kornfeld H., Riedel N., Viglianti G. A., Hirsch V., Mullins J. I. 1987; Cloning of HTLV-4 and its relation to simian and human immunodeficiency viruses. Nature 326:610–613
    [Google Scholar]
  25. Lackner A. A., Vogel P., Ramos R. A., Kluge J. D., Marthas M. 1994; Early events in tissues during infection with pathogenic (SIVmac239) and nonpathogenic (SIVmac1A11) molecular clones of simian immunodeficiency virus. American Journal of Pathology 145:428–439
    [Google Scholar]
  26. Lehner T., Wang Y., Cranage M., Bergmeier L. A., Mitchell E., Tao L., Hall G., Dennis M., Cook N., Brookes R., Klavinskis L., Jones I., Doyle C., Ward R. 1996; Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nature Medicine 2:767–775
    [Google Scholar]
  27. Levy J. A. 1993; HIV pathogenesis and long-term survival. AIDS 7:1401–1410
    [Google Scholar]
  28. Luster A. D. 1998; Chemokines – chemotactic cytokines that mediate inflammation. New England Journal of Medicine 338:436–445
    [Google Scholar]
  29. Moore J. P., Trkola A., Dragic T. 1997; Co-receptors for HIV-1 entry. Current Opinion In Immunology 9:551–562
    [Google Scholar]
  30. Norley S., Beer B., Binninger-Schinzel D., Cosma C., Kurth R. 1996; Protection from pathogenic SIVmac challenge following shortterm infection with Nef-deficient attenuated virus. Virology 219:195–205
    [Google Scholar]
  31. Paxton W. A., Liu R., Kang S., Wu L., Gingeras T. R., Landau N. R., Mackay C. R., Koup R. A. 1998; Reduced HIV-1 infectability ofCD4+ lymphocytes from exposed-uninfected individuals: association with low expression of CCR5 and high production of beta-chemokines. Virology 244:66–73
    [Google Scholar]
  32. Rosenberg Y. J., Cafaro A., Brennan T., Greenhouse J. G., McKinnon K., Bellah S., Yalley-Ogunro J., Gartner S., Lewis M. G. 1997; Characteristics of the CD8+ lymphocytosis during primary simian immunodeficiency virus infections. AIDS 11:959–968
    [Google Scholar]
  33. Ruprecht R. M., Baba T. W., Li A., Ayehunie S., Hu Y., Liska V., Rasmussen R., Sharma P. L. 1996; Live attenuated HIV as a vaccine for AIDS: pros and cons. Seminars in Virology 7:147–155
    [Google Scholar]
  34. Saha K., Volsky D. J. 1998; Are beta-chemokines innocent bystanders in HIV type 1 disease progression?. AIDS Research and Human Retroviruses 14:1–2
    [Google Scholar]
  35. Sasseville V. G., Smith M. M., Mackay C. R., Pauley D. R., Mansfield K. G., Ringler D. J., Lackner A. A. 1996; Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis. American Journal of Pathology 149:1459–1467
    [Google Scholar]
  36. Saukkonen J. J., Furfaro S., Mahoney K. M., Strieter R. M., Burdick M., Wright E. A., Kornfeld H., Berman J. S. 1997; In vitro transendothelial migration of blood T lymphocytes from HIV-infected individuals. AIDS 11:1595–1601
    [Google Scholar]
  37. Schmidtmayerova H., Nottet H. S. L. M., Nuovo G., Raabe T., Flanagan C. R., Dubrovsky L., Gendelman H. E., Cerami A., Bukrinsky M., Sherry B. 1996; Human immunodeficiency virus type 1 infection alters chemokine p expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes. Proceedings of the National Academy of Sciences, USA 93:700–704
    [Google Scholar]
  38. Schrum S., Probst P., Fleischer B., Zipfel P. F. 1996; Synthesis of the CC-chemokines MIP-1a, MIP-1p, and RANTES is associated with type 1 immune response. Journal of Immunology 157:3598–3604
    [Google Scholar]
  39. Sharpe S. A., Whatmore A. M., Hall G. A., Cranage M. P. 1997; Macaques infected with attenuated simian immunodeficiency virus resist superinfection with virulence-revertant virus. Journal of General Virology 78:1923–1927
    [Google Scholar]
  40. Simon M. A., Chalifoux L. V., Ringler D. 1992; Pathologic features of SIV-induced disease and the association of macrophage infection with disease evolution. AIDS Research and Human Retroviruses 8:327–337
    [Google Scholar]
  41. Spain B. A., Soliman D. M., Sidner R. A., Twigg H. L. 1995; Enhanced proliferation and IL-2 secretion by lung lymphocytes from HIV-infected subjects. American Journal of Physiology 269:L498–506
    [Google Scholar]
  42. Stahl-Hennig C., Dittmer U., Nisslein T., Petry H., Jurkiewicz E., Fuchs D., Wachter H., Matz-Rensing K., Kuhn E. M., Kaup F. J., Rud E. W., Hunsmann G. 1996; Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus. Journal of General Virology 77:2969–2981
    [Google Scholar]
  43. Taub D. D., Ortaldo J. R., Turcovski-Corrales S. M., Key M. L., Longo D. L., Murphy W. J. 1996a; Beta chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production. Journal of Leukocyte Biology 59:81–89
    [Google Scholar]
  44. Taub D. D., Turcovski-Corrales S. M., Key M. L., Longo D. L., Murphy W. J. 1996b; Chemokines and T lymphocyte activation. I. Beta chemokines costimulate human T lymphocyte activation in vitro. Journal of Immunology 156:2095–2103
    [Google Scholar]
  45. Tedla N., Palladinetti P., Kelly M., Kumar R. K., DiGirolamo N., Chattophadhay U., Cooke B., Truskett P., Dwyer J., Wakefield D., Lloyd A. 1996; Chemokines and T lymphocyte recruitment to lymph nodes in HIV infection. American Journal of Pathology 148:1367–1373
    [Google Scholar]
  46. Titti F., Sernicola L., Geraci A., Panzini G., Di Fabio S., Belli R., Monardo F., Borsetti A., Maggiorella M. T., Koanga-Mogtomo M., Corrias F., Zamarchi R., Amadori A., Chieco-Bianchi L., Verani P. 1997; Live attenuated simian immunodeficiency virus prevents superinfection by cloned SIVmac251 cynomolgus monkeys. Journal of General Virology 78:2529–2539
    [Google Scholar]
  47. Triozzi P. L., Bresler H. S., Aldrich W. A. 1998; HIV type 1-reactive chemokine-producing CD8+ and CD4+ cells expanded from infected lymph nodes. AIDS Research and Human Retroviruses 14:643–649
    [Google Scholar]
  48. Trkola A., Paxton W. A., Monard S. P., Hoxie J. A., Siani M. A., Thompson D. A., Wu L., Mackay C. R., Horuk R., Moore J. P. 1988; Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines. Journal of Virology 72:396–404
    [Google Scholar]
  49. Ullum H., Cozzi Lepri A., Victor J., Aladdin H., Phillips A. N., Gerstoft J., Skinhoj P., Pedersen B. K. 1998; Production of beta-chemokines in human immunodeficiency virus (HIV) infection: evidence that high levels ofmacrophage inflammatory protein-lbeta are associated with a decreased risk of HIV disease progression. Journal of Infectious Diseases 177:331–336
    [Google Scholar]
  50. Veazey R. S., Lackner A. A. 1998; The gastrointestinal tract and the pathogenesis of AIDS. AIDS 12:S35–S42
    [Google Scholar]
  51. Wagner L., Yang O. O., Garcia-Zepeda E. A., Ge Y., Kalams S. A., Walker B. D., Pasternack M. S., Luster A. D. 1998; Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans. Nature 391:908–911
    [Google Scholar]
  52. Wang Y., Tao L., Mitchell E., Bogers W. M., Doyle C., Bravery C. A., Bergmeier L. A., Kelly C. G., Heeney J. L., Lehner T. 1998; Generation of CD8 suppressor factor and beta chemokines, induced by xenogeneic immunization, in the prevention of simian immunodeficiency virus infection in macaques. Proceedings of the National Academy ofSciences, USA 95:5223–5228
    [Google Scholar]
  53. Wyand M. S., Manson K. H., Garcia-Moll M., Montefiori D., Desrosiers R. C. 1996; Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. Journal of Virology 70:3724–3733
    [Google Scholar]
  54. Zagury D., Bernard J., Leibowitch J., Safai B., Groopman J. E., Feldman M., Sangadharan M. G., Gallo R. C. 1984; HTLV-III in cells cultured from semen of two patients with AIDS. Science 226:449–451
    [Google Scholar]
  55. Zagury D., Lachgar A., Chams V., Fall L. S., Bernard J., Zagury J. F., Bizzini B., Gringeri A., Santagostino E., Rappaport J., Feldman M., O’Brien S. J., Burny A., Gallo R. C. 1998; C-C chemokines, pivotal in protection against HIV type 1 infection. Proceedings of the National Academy of Sciences, USA 95:3857–3861
    [Google Scholar]
  56. Zambello R., Trentin L., Benetti R., Cipriani A., Crivellaro C., Cadrobbi P., Agostini C., Semenzato G. 1992; Expression of a functional p75 interleukin-2 receptor on lung lymphocytes from patients with human immunodeficiency virus type 1 (HIV-1) infection. Journal of Clinical Immunology 12:371–380
    [Google Scholar]
  57. Zou W., Lackner A. A., Simon M., Durand-Gasselin I., Galanaud P., Desrosiers R. C., Emilie D. 1997; Early cytokine and chemokine gene expression in lymph nodes of macaques infected with simian immunodeficiency virus is predictive of disease outcome and vaccine efficacy. Journal of Virology 711227–1236
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-80-3-767
Loading
/content/journal/jgv/10.1099/0022-1317-80-3-767
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error